Target
D(3) dopamine receptor
Ligand
BDBM50207147
Substrate
n/a
Meas. Tech.
ChEMBL_1630050 (CHEMBL3872756)
Ki
0.210000±n/a nM
Citation
 Chen, XWSun, YYFu, LLi, JQ Synthesis and pharmacological characterization of novel N-(trans-4-(2-(4-(benzo[d]isothiazol-3-yl)piperazin-1-yl)ethyl)cyclohexyl)amides as potential multireceptor atypical antipsychotics. Eur J Med Chem 123:332-353 (2016) [PubMed]  Article 
Target
Name:
D(3) dopamine receptor
Synonyms:
DOPAMINE D3 | DRD3 | DRD3_HUMAN | Dopamine D3 receptor | Dopamine D3 receptor (D3) | Dopamine D3 receptor (D3R) | Dopamine receptor | Dopamine receptor (D3) | Dopamine receptor D3
Type:
n/a
Mol. Mass.:
44243.43
Organism:
Homo sapiens (Human)
Description:
n/a
Residue:
400
Sequence:
MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC
  
Inhibitor
Name:
BDBM50207147
Synonyms:
CHEMBL3956720
Type:
Small organic molecule
Emp. Form.:
C23H32N4OS
Mol. Mass.:
412.591
SMILES:
O=C(N[C@H]1CC[C@H](CCN2CCN(CC2)c2nsc3ccccc23)CC1)C1CC1 |r,wU:3.2,wD:6.6,(14.82,-26.62,;14.05,-25.29,;14.82,-23.96,;16.36,-23.96,;17.13,-22.62,;18.67,-22.62,;19.44,-23.96,;20.98,-23.96,;21.75,-22.62,;23.29,-22.62,;24.05,-21.29,;25.59,-21.29,;26.37,-22.62,;25.59,-23.96,;24.05,-23.96,;27.9,-22.62,;28.8,-23.87,;30.27,-23.39,;30.27,-21.85,;31.41,-20.82,;31.09,-19.32,;29.63,-18.85,;28.48,-19.88,;28.8,-21.38,;18.67,-25.29,;17.13,-25.29,;12.51,-25.29,;11.17,-26.05,;11.17,-24.51,)|
Structure:
Search PDB for entries with ligand similarity: